

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | COPI coating of Golgi vesicle (GO:0048205) | 5.05520978 |
| 2 | Golgi transport vesicle coating (GO:0048200) | 5.05520978 |
| 3 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 4.86261054 |
| 4 | modulation by symbiont of host immune response (GO:0052553) | 4.86261054 |
| 5 | positive regulation by symbiont of host defense response (GO:0052509) | 4.86261054 |
| 6 | modulation by symbiont of host defense response (GO:0052031) | 4.86261054 |
| 7 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 4.86261054 |
| 8 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 4.86261054 |
| 9 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 4.40082963 |
| 10 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 4.40082963 |
| 11 | response to peptidoglycan (GO:0032494) | 4.36057185 |
| 12 | neutrophil activation involved in immune response (GO:0002283) | 4.26687498 |
| 13 | immunoglobulin mediated immune response (GO:0016064) | 4.18709132 |
| 14 | regulation of interferon-beta biosynthetic process (GO:0045357) | 4.04959948 |
| 15 | Arp2/3 complex-mediated actin nucleation (GO:0034314) | 3.96030887 |
| 16 | antigen processing and presentation of endogenous antigen (GO:0019883) | 3.95682981 |
| 17 | respiratory burst (GO:0045730) | 3.82528553 |
| 18 | positive regulation of interferon-alpha production (GO:0032727) | 3.74649949 |
| 19 | regulation of antigen processing and presentation of peptide antigen (GO:0002583) | 3.71318039 |
| 20 | positive regulation of Cdc42 GTPase activity (GO:0043089) | 3.64863734 |
| 21 | positive regulation of interleukin-8 biosynthetic process (GO:0045416) | 3.63874381 |
| 22 | barbed-end actin filament capping (GO:0051016) | 3.55921770 |
| 23 | regulation of interferon-alpha production (GO:0032647) | 3.53212505 |
| 24 | glycosphingolipid catabolic process (GO:0046479) | 3.50748551 |
| 25 | positive regulation of antigen processing and presentation (GO:0002579) | 3.49046030 |
| 26 | regulation of early endosome to late endosome transport (GO:2000641) | 3.45245962 |
| 27 | neutrophil mediated immunity (GO:0002446) | 3.42305082 |
| 28 | negative regulation of erythrocyte differentiation (GO:0045647) | 3.41107498 |
| 29 | macrophage activation involved in immune response (GO:0002281) | 3.40399025 |
| 30 | response to immune response of other organism involved in symbiotic interaction (GO:0052564) | 3.33991966 |
| 31 | response to host immune response (GO:0052572) | 3.33991966 |
| 32 | response to fungus (GO:0009620) | 3.31892320 |
| 33 | B cell mediated immunity (GO:0019724) | 3.25397388 |
| 34 | regulation of interleukin-8 biosynthetic process (GO:0045414) | 3.25240444 |
| 35 | cellular extravasation (GO:0045123) | 3.23197654 |
| 36 | glycolipid catabolic process (GO:0019377) | 3.18769161 |
| 37 | negative regulation of endoplasmic reticulum calcium ion concentration (GO:0032471) | 3.18510095 |
| 38 | protein localization to endosome (GO:0036010) | 3.18399132 |
| 39 | response to muramyl dipeptide (GO:0032495) | 3.16911217 |
| 40 | production of molecular mediator involved in inflammatory response (GO:0002532) | 3.15904481 |
| 41 | pinocytosis (GO:0006907) | 3.15464641 |
| 42 | proline biosynthetic process (GO:0006561) | 3.13862804 |
| 43 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 3.12558736 |
| 44 | maintenance of protein localization in endoplasmic reticulum (GO:0035437) | 3.12224858 |
| 45 | retrograde vesicle-mediated transport, Golgi to ER (GO:0006890) | 3.10920279 |
| 46 | protein retention in ER lumen (GO:0006621) | 3.10502512 |
| 47 | neutrophil activation (GO:0042119) | 3.10131531 |
| 48 | DNA deamination (GO:0045006) | 3.07928682 |
| 49 | pentose-phosphate shunt (GO:0006098) | 3.07156025 |
| 50 | response to host defenses (GO:0052200) | 3.02816088 |
| 51 | response to defenses of other organism involved in symbiotic interaction (GO:0052173) | 3.02816088 |
| 52 | response to host (GO:0075136) | 3.02816088 |
| 53 | mitotic chromosome condensation (GO:0007076) | 3.01757289 |
| 54 | actin nucleation (GO:0045010) | 2.99112235 |
| 55 | negative regulation of phagocytosis (GO:0050765) | 2.98997618 |
| 56 | positive regulation of B cell differentiation (GO:0045579) | 2.98939357 |
| 57 | regulation of antigen processing and presentation (GO:0002577) | 2.98253539 |
| 58 | * leukotriene metabolic process (GO:0006691) | 2.96877410 |
| 59 | superoxide anion generation (GO:0042554) | 2.96609460 |
| 60 | glucose 6-phosphate metabolic process (GO:0051156) | 2.95611049 |
| 61 | granulocyte activation (GO:0036230) | 2.95526640 |
| 62 | regulation of B cell receptor signaling pathway (GO:0050855) | 2.92747325 |
| 63 | negative regulation of interleukin-12 production (GO:0032695) | 2.92208192 |
| 64 | defense response to fungus (GO:0050832) | 2.92132644 |
| 65 | positive regulation of gamma-delta T cell activation (GO:0046645) | 2.89883359 |
| 66 | positive regulation of interferon-beta production (GO:0032728) | 2.89281536 |
| 67 | hepatocyte apoptotic process (GO:0097284) | 2.86809178 |
| 68 | response to laminar fluid shear stress (GO:0034616) | 2.85767865 |
| 69 | response to thyroid hormone (GO:0097066) | 2.83702916 |
| 70 | desmosome organization (GO:0002934) | 2.83410800 |
| 71 | NADPH regeneration (GO:0006740) | 2.80778088 |
| 72 | mannose metabolic process (GO:0006013) | 2.80528614 |
| 73 | cellular response to thyroid hormone stimulus (GO:0097067) | 2.77775396 |
| 74 | regulation of superoxide anion generation (GO:0032928) | 2.77422524 |
| 75 | antigen processing and presentation via MHC class Ib (GO:0002475) | 2.77094541 |
| 76 | detection of molecule of bacterial origin (GO:0032490) | 2.76851935 |
| 77 | embryonic process involved in female pregnancy (GO:0060136) | 2.76780614 |
| 78 | reactive oxygen species biosynthetic process (GO:1903409) | 2.75658305 |
| 79 | protein maturation by protein folding (GO:0022417) | 2.74037924 |
| 80 | epithelial cell-cell adhesion (GO:0090136) | 2.73802641 |
| 81 | leukocyte mediated cytotoxicity (GO:0001909) | 2.71065540 |
| 82 | hyaluronan catabolic process (GO:0030214) | 2.70437648 |
| 83 | lipopolysaccharide-mediated signaling pathway (GO:0031663) | 2.68528385 |
| 84 | negative regulation of granulocyte differentiation (GO:0030853) | 2.67341444 |
| 85 | interferon-gamma secretion (GO:0072643) | 2.66172281 |
| 86 | regulation of mast cell degranulation (GO:0043304) | 2.65760531 |
| 87 | stress fiber assembly (GO:0043149) | 2.62494589 |
| 88 | NIK/NF-kappaB signaling (GO:0038061) | 2.61983616 |
| 89 | regulation of mammary gland epithelial cell proliferation (GO:0033599) | 2.61586623 |
| 90 | regulation of mast cell activation (GO:0033003) | 2.60363882 |
| 91 | myeloid leukocyte mediated immunity (GO:0002444) | 2.60001869 |
| 92 | modulation of growth of symbiont involved in interaction with host (GO:0044144) | 2.59436939 |
| 93 | regulation of growth of symbiont in host (GO:0044126) | 2.59436939 |
| 94 | negative regulation of growth of symbiont in host (GO:0044130) | 2.59436939 |
| 95 | negative regulation of growth of symbiont involved in interaction with host (GO:0044146) | 2.59436939 |
| 96 | epithelial cell differentiation involved in prostate gland development (GO:0060742) | 2.59111562 |
| 97 | apoptotic process involved in morphogenesis (GO:0060561) | 2.58656340 |
| 98 | ceramide catabolic process (GO:0046514) | 2.58367655 |
| 99 | myeloid cell activation involved in immune response (GO:0002275) | 2.58345088 |
| 100 | maternal placenta development (GO:0001893) | 2.58224066 |
| 101 | hypotonic response (GO:0006971) | 2.57324018 |
| 102 | NADH metabolic process (GO:0006734) | 2.56055168 |
| 103 | activation of Rac GTPase activity (GO:0032863) | 2.55791242 |
| 104 | mitochondrial calcium ion transport (GO:0006851) | 2.55672482 |
| 105 | response to interferon-beta (GO:0035456) | 2.55343193 |
| 106 | positive regulation of membrane protein ectodomain proteolysis (GO:0051044) | 2.53831383 |
| 107 | lipoxygenase pathway (GO:0019372) | 2.53784513 |
| 108 | mature B cell differentiation involved in immune response (GO:0002313) | 2.53756300 |
| 109 | regulation of tumor necrosis factor biosynthetic process (GO:0042534) | 2.52799469 |
| 110 | adhesion of symbiont to host (GO:0044406) | 2.52597939 |
| 111 | type I interferon signaling pathway (GO:0060337) | 2.52328916 |
| 112 | cellular response to type I interferon (GO:0071357) | 2.52328916 |
| 113 | peptide catabolic process (GO:0043171) | 2.50933333 |
| 114 | negative regulation of myeloid cell apoptotic process (GO:0033033) | 2.50726589 |
| 115 | amyloid precursor protein catabolic process (GO:0042987) | 2.50201382 |
| 116 | macrophage activation (GO:0042116) | 2.50067648 |
| 117 | response to type I interferon (GO:0034340) | 2.49892029 |
| 118 | leukocyte aggregation (GO:0070486) | 2.48911166 |
| 119 | regulation of cellular extravasation (GO:0002691) | 2.48510884 |
| 120 | activation of cysteine-type endopeptidase activity involved in apoptotic process by cytochrome c (GO | 2.47832630 |
| 121 | hemidesmosome assembly (GO:0031581) | 2.47673095 |
| 122 | glucose catabolic process (GO:0006007) | 2.47563321 |
| 123 | myeloid dendritic cell activation (GO:0001773) | 2.47203040 |
| 124 | regulation of mast cell activation involved in immune response (GO:0033006) | 2.46574648 |
| 125 | regulation of dendritic cell antigen processing and presentation (GO:0002604) | 2.46064609 |
| 126 | response to protozoan (GO:0001562) | 2.44831144 |
| 127 | response to interferon-alpha (GO:0035455) | 2.44819232 |
| 128 | urea cycle (GO:0000050) | 2.44628640 |
| 129 | regulation of RIG-I signaling pathway (GO:0039535) | 2.44098515 |
| 130 | basement membrane organization (GO:0071711) | 2.43418869 |
| 131 | defense response to protozoan (GO:0042832) | 2.43301894 |
| 132 | hydrogen peroxide biosynthetic process (GO:0050665) | 2.43282910 |
| 133 | adhesion of symbiont to host cell (GO:0044650) | 2.41938298 |
| 134 | virion attachment to host cell (GO:0019062) | 2.41938298 |
| 135 | GDP-mannose metabolic process (GO:0019673) | 2.40714639 |
| 136 | regulation of interferon-beta production (GO:0032648) | 2.40537039 |
| 137 | cellular response to interferon-beta (GO:0035458) | 2.38207378 |
| 138 | detection of other organism (GO:0098543) | 2.37968185 |
| 139 | modulation by symbiont of host cellular process (GO:0044068) | 2.37951708 |
| 140 | killing of cells in other organism involved in symbiotic interaction (GO:0051883) | 2.37232787 |
| 141 | disruption of cells of other organism involved in symbiotic interaction (GO:0051818) | 2.37232787 |
| 142 | negative regulation of mast cell activation (GO:0033004) | 2.37068224 |
| 143 | sphingolipid catabolic process (GO:0030149) | 2.37029523 |
| 144 | branching involved in mammary gland duct morphogenesis (GO:0060444) | 2.36098980 |
| 145 | natural killer cell mediated cytotoxicity (GO:0042267) | 2.35831478 |
| 146 | natural killer cell mediated immunity (GO:0002228) | 2.35831478 |
| 147 | detection of bacterium (GO:0016045) | 2.35231485 |
| 148 | positive regulation of syncytium formation by plasma membrane fusion (GO:0060143) | 2.34923120 |
| 149 | apoptotic cell clearance (GO:0043277) | 2.34511074 |
| 150 | regulation of leukocyte degranulation (GO:0043300) | 2.33785583 |
| 151 | membrane lipid catabolic process (GO:0046466) | 2.33009608 |
| 152 | negative regulation of protein localization to plasma membrane (GO:1903077) | 2.31659416 |
| 153 | pentose metabolic process (GO:0019321) | 2.31424008 |
| 154 | oligosaccharide catabolic process (GO:0009313) | 2.30251282 |
| 155 | embryo implantation (GO:0007566) | 2.28170410 |
| 156 | formation of translation preinitiation complex (GO:0001731) | 2.26502432 |
| 157 | urea metabolic process (GO:0019627) | 2.25366859 |
| 158 | regulation of apoptotic process involved in morphogenesis (GO:1902337) | 2.24855344 |
| 159 | negative regulation of viral release from host cell (GO:1902187) | 2.24567079 |
| 160 | activation of signaling protein activity involved in unfolded protein response (GO:0006987) | 2.23919323 |
| 161 | positive regulation of nuclease activity (GO:0032075) | 2.23455771 |
| 162 | cell-substrate junction assembly (GO:0007044) | 2.22823218 |
| 163 | skin morphogenesis (GO:0043589) | 2.19860278 |
| 164 | regulation of extracellular matrix disassembly (GO:0010715) | 2.17959883 |
| 165 | vesicle coating (GO:0006901) | 2.17630077 |
| 166 | regulation of vitamin metabolic process (GO:0030656) | 2.17465697 |
| 167 | negative regulation of toll-like receptor 4 signaling pathway (GO:0034144) | 2.17384175 |
| 168 | positive regulation of leukocyte degranulation (GO:0043302) | 2.15758892 |
| 169 | regulation of podosome assembly (GO:0071801) | 2.15575861 |
| 170 | positive regulation of keratinocyte differentiation (GO:0045618) | 2.15314344 |
| 171 | adherens junction assembly (GO:0034333) | 2.14648284 |
| 172 | regulation of Arp2/3 complex-mediated actin nucleation (GO:0034315) | 2.14104097 |
| 173 | positive regulation of receptor recycling (GO:0001921) | 2.13370330 |
| 174 | angiotensin maturation (GO:0002003) | 2.12814417 |
| 175 | pyrimidine nucleoside salvage (GO:0043097) | 2.12599506 |
| 176 | pyrimidine-containing compound salvage (GO:0008655) | 2.12599506 |
| 177 | COPII vesicle coating (GO:0048208) | 2.12053524 |
| 178 | endoplasmic reticulum calcium ion homeostasis (GO:0032469) | 2.12022727 |
| 179 | cellular protein complex localization (GO:0034629) | 2.11865409 |
| 180 | regulation of integrin activation (GO:0033623) | 2.10870317 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | E2F7_22180533_ChIP-Seq_HELA_Human | 4.90311233 |
| 2 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 4.08103540 |
| 3 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 3.92156812 |
| 4 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 2.77783907 |
| 5 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 2.77627901 |
| 6 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 2.74587113 |
| 7 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 2.71049588 |
| 8 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 2.64448804 |
| 9 | * SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.62944626 |
| 10 | * NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.46298591 |
| 11 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 2.43151320 |
| 12 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 2.40292448 |
| 13 | ZNF263_19887448_ChIP-Seq_K562_Human | 2.31256883 |
| 14 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 2.25168039 |
| 15 | * EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 2.23936930 |
| 16 | VDR_21846776_ChIP-Seq_THP-1_Human | 2.18645699 |
| 17 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 2.16371184 |
| 18 | * SPI1_23547873_ChIP-Seq_NB4_Human | 2.14056337 |
| 19 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 2.13679212 |
| 20 | * BRD4_27068464_Chip-Seq_AML-cells_Mouse | 2.09076865 |
| 21 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 2.05199648 |
| 22 | * RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.98220098 |
| 23 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 1.95152105 |
| 24 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.90556955 |
| 25 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 1.88130443 |
| 26 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.83425937 |
| 27 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 1.79996347 |
| 28 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.79754479 |
| 29 | FOXM1_23109430_ChIP-Seq_U2OS_Human | 1.78377374 |
| 30 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 1.77185689 |
| 31 | * KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.76826068 |
| 32 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.76410011 |
| 33 | MYC_22102868_ChIP-Seq_BL_Human | 1.73149835 |
| 34 | SCL_19346495_ChIP-Seq_HPC-7_Human | 1.71567226 |
| 35 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 1.71544744 |
| 36 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 1.69601313 |
| 37 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.68607767 |
| 38 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 1.68222565 |
| 39 | KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.67960530 |
| 40 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.64736027 |
| 41 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 1.61788811 |
| 42 | MYBL1_21750041_ChIP-ChIP_SPERMATOCYTES_Mouse | 1.58454679 |
| 43 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 1.58262452 |
| 44 | MAF_26560356_Chip-Seq_TH1_Human | 1.56278222 |
| 45 | * KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.55199257 |
| 46 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.55039222 |
| 47 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.52703639 |
| 48 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 1.50838630 |
| 49 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.50382292 |
| 50 | MYC_18555785_ChIP-Seq_MESCs_Mouse | 1.49616735 |
| 51 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 1.47444613 |
| 52 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.47320912 |
| 53 | KLF4_18358816_ChIP-ChIP_MESCs_Mouse | 1.47259880 |
| 54 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.47190592 |
| 55 | DACH1_20351289_ChIP-Seq_MDA-MB-231_Human | 1.45445692 |
| 56 | MYB_26560356_Chip-Seq_TH2_Human | 1.43045004 |
| 57 | KLF4_18555785_ChIP-Seq_MESCs_Mouse | 1.42404026 |
| 58 | FOXM1_25889361_ChIP-Seq_OE33_AND_U2OS_Human | 1.39270134 |
| 59 | ATF3_27146783_Chip-Seq_COLON_Human | 1.38839360 |
| 60 | HCFC1_20581084_ChIP-Seq_MESCs_Mouse | 1.37912993 |
| 61 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.37773366 |
| 62 | SPI1_23127762_ChIP-Seq_K562_Human | 1.32338520 |
| 63 | * KDM2B_26808549_Chip-Seq_DND41_Human | 1.32303475 |
| 64 | MYB_26560356_Chip-Seq_TH1_Human | 1.31740497 |
| 65 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 1.31369859 |
| 66 | UTX_26944678_Chip-Seq_JUKART_Human | 1.31369584 |
| 67 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 1.31299092 |
| 68 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.30664610 |
| 69 | * TCFAP2C_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 1.30331452 |
| 70 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.29873222 |
| 71 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 1.29473024 |
| 72 | * SMARCA4_20176728_ChIP-ChIP_TSCs_Mouse | 1.29341379 |
| 73 | * CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.29280196 |
| 74 | RUNX2_24764292_ChIP-Seq_MC3T3_Mouse | 1.29225009 |
| 75 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.29189199 |
| 76 | NCOR1_26117541_ChIP-Seq_K562_Human | 1.27915718 |
| 77 | * ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.27596662 |
| 78 | * P300_27058665_Chip-Seq_ZR-75-30cells_Human | 1.27071059 |
| 79 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 1.26540874 |
| 80 | ERG_20887958_ChIP-Seq_HPC-7_Mouse | 1.26255476 |
| 81 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.25651786 |
| 82 | UBF1/2_26484160_Chip-Seq_HMEC-DERIVED_Human | 1.25018380 |
| 83 | * ZFX_18555785_ChIP-Seq_MESCs_Mouse | 1.24378635 |
| 84 | ZFP281_18358816_ChIP-ChIP_MESCs_Mouse | 1.24245589 |
| 85 | ELF3_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.23286810 |
| 86 | * GATA2_22383799_ChIP-Seq_G1ME_Mouse | 1.22597274 |
| 87 | HSF1_23293686_ChIP-Seq_STHDH_STRIATAL_Mouse | 1.21952125 |
| 88 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 1.20740225 |
| 89 | TET1_21451524_ChIP-Seq_MESCs_Mouse | 1.20715691 |
| 90 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 1.19915194 |
| 91 | E2F4_17652178_ChIP-ChIP_JURKAT_Human | 1.19593965 |
| 92 | * MYC_18358816_ChIP-ChIP_MESCs_Mouse | 1.19546390 |
| 93 | TFEB_21752829_ChIP-Seq_HELA_Human | 1.18069329 |
| 94 | JARID1A_20064375_ChIP-Seq_MESCs_Mouse | 1.17880049 |
| 95 | CTCF_27219007_Chip-Seq_ERYTHROID_Human | 1.17770804 |
| 96 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.17509675 |
| 97 | NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 1.17285781 |
| 98 | * PU_27001747_Chip-Seq_BMDM_Mouse | 1.16845376 |
| 99 | CCND1_20090754_ChIP-ChIP_RETINA_Mouse | 1.14886241 |
| 100 | HOXB4_20404135_ChIP-ChIP_EML_Mouse | 1.13849914 |
| 101 | GFI1B_20887958_ChIP-Seq_HPC-7_Mouse | 1.13589889 |
| 102 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 1.13545133 |
| 103 | * SA1_27219007_Chip-Seq_ERYTHROID_Human | 1.13108734 |
| 104 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 1.11145128 |
| 105 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 1.10383691 |
| 106 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 1.10269526 |
| 107 | P68_20966046_ChIP-Seq_HELA_Human | 1.09625341 |
| 108 | * CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 1.08951831 |
| 109 | AR_21909140_ChIP-Seq_LNCAP_Human | 1.08185638 |
| 110 | SMAD4_19686287_ChIP-ChIP_HaCaT_Human | 1.05856744 |
| 111 | * MYC_19079543_ChIP-ChIP_MESCs_Mouse | 1.04632985 |
| 112 | SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.04286421 |
| 113 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 1.03791804 |
| 114 | E2F1_21310950_ChIP-Seq_MCF-7_Human | 1.03390835 |
| 115 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.02310977 |
| 116 | KDM6A_18722178_ChIP-ChIP_U937_AND_SAOS2_Human | 1.02033539 |
| 117 | * ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 1.01980974 |
| 118 | GATA1_22025678_ChIP-Seq_K562_Human | 1.01869553 |
| 119 | * KDM2B_26808549_Chip-Seq_K562_Human | 1.01630026 |
| 120 | CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.01627842 |
| 121 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.01515937 |
| 122 | MAF_26560356_Chip-Seq_TH2_Human | 1.01503004 |
| 123 | * KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 1.01398631 |
| 124 | CREB1_23762244_ChIP-Seq_HIPPOCAMPUS_Rat | 1.00970798 |
| 125 | CREB1_20920259_ChIP-Seq_GC1-SPG_Mouse | 1.00817336 |
| 126 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 1.00784294 |
| 127 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.00127059 |
| 128 | NELFA_20434984_ChIP-Seq_ESCs_Mouse | 0.99924047 |
| 129 | TCF7_22412390_ChIP-Seq_EML_Mouse | 0.99829539 |
| 130 | BCOR_27268052_Chip-Seq_Bcells_Human | 0.97976970 |
| 131 | CDX2_20551321_ChIP-Seq_CACO-2_Human | 0.97626834 |
| 132 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 0.96607575 |
| 133 | * P63_26484246_Chip-Seq_KERATINOCYTES_Human | 0.96545956 |
| 134 | SMC4_20622854_ChIP-Seq_HELA_Human | 0.96475716 |
| 135 | CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.96034022 |
| 136 | * CREB1_26743006_Chip-Seq_LNCaP_Human | 0.95578837 |
| 137 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 0.95209574 |
| 138 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 0.94833886 |
| 139 | ETS1_20019798_ChIP-Seq_JURKAT_Human | 0.94824936 |
| 140 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 0.94221787 |
| 141 | MYC_19030024_ChIP-ChIP_MESCs_Mouse | 0.93975205 |
| 142 | * E2F1_18555785_ChIP-Seq_MESCs_Mouse | 0.93499259 |
| 143 | GATA6_25053715_ChIP-Seq_YYC3_Human | 0.93065573 |
| 144 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 0.92836072 |
| 145 | * KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.92149386 |
| 146 | * GATA4_25053715_ChIP-Seq_YYC3_Human | 0.90931499 |
| 147 | DCP1A_22483619_ChIP-Seq_HELA_Human | 0.90587531 |
| 148 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 0.90393381 |
| 149 | LXR_22292898_ChIP-Seq_THP-1_Human | 0.89205899 |
| 150 | GABP_17652178_ChIP-ChIP_JURKAT_Human | 0.89037384 |
| 151 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 0.88524925 |
| 152 | * RACK7_27058665_Chip-Seq_MCF-7_Human | 0.87820651 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0001835_abnormal_antigen_presentation | 3.27763083 |
| 2 | MP0003436_decreased_susceptibility_to | 3.18064883 |
| 3 | MP0010234_abnormal_vibrissa_follicle | 3.03848591 |
| 4 | MP0005058_abnormal_lysosome_morphology | 2.86472210 |
| 5 | MP0005451_abnormal_body_composition | 2.69483550 |
| 6 | MP0002419_abnormal_innate_immunity | 2.66718531 |
| 7 | MP0009785_altered_susceptibility_to | 2.65518465 |
| 8 | MP0009840_abnormal_foam_cell | 2.61728984 |
| 9 | MP0005025_abnormal_response_to | 2.45351668 |
| 10 | MP0003303_peritoneal_inflammation | 2.37211851 |
| 11 | MP0002877_abnormal_melanocyte_morpholog | 2.35052740 |
| 12 | MP0002148_abnormal_hypersensitivity_rea | 2.28296835 |
| 13 | MP0003693_abnormal_embryo_hatching | 2.22754504 |
| 14 | MP0005464_abnormal_platelet_physiology | 2.16722849 |
| 15 | MP0005000_abnormal_immune_tolerance | 2.13270885 |
| 16 | MP0002452_abnormal_antigen_presenting | 2.10871055 |
| 17 | MP0008438_abnormal_cutaneous_collagen | 2.09796900 |
| 18 | MP0002396_abnormal_hematopoietic_system | 2.06168339 |
| 19 | MP0010155_abnormal_intestine_physiology | 2.02795320 |
| 20 | MP0002796_impaired_skin_barrier | 2.02645284 |
| 21 | MP0000685_abnormal_immune_system | 2.00140446 |
| 22 | MP0000490_abnormal_crypts_of | 1.99444617 |
| 23 | MP0005387_immune_system_phenotype | 1.98183487 |
| 24 | MP0001790_abnormal_immune_system | 1.98183487 |
| 25 | MP0009333_abnormal_splenocyte_physiolog | 1.97963901 |
| 26 | MP0003724_increased_susceptibility_to | 1.94933047 |
| 27 | MP0003300_gastrointestinal_ulcer | 1.93106085 |
| 28 | MP0003453_abnormal_keratinocyte_physiol | 1.91648032 |
| 29 | MP0006082_CNS_inflammation | 1.90149072 |
| 30 | MP0002723_abnormal_immune_serum | 1.88774841 |
| 31 | MP0001800_abnormal_humoral_immune | 1.87986503 |
| 32 | MP0001819_abnormal_immune_cell | 1.86181351 |
| 33 | MP0001533_abnormal_skeleton_physiology | 1.85556990 |
| 34 | MP0001873_stomach_inflammation | 1.85556404 |
| 35 | MP0003191_abnormal_cellular_cholesterol | 1.85248867 |
| 36 | MP0002420_abnormal_adaptive_immunity | 1.84140821 |
| 37 | MP0003806_abnormal_nucleotide_metabolis | 1.82702030 |
| 38 | MP0003183_abnormal_peptide_metabolism | 1.80866945 |
| 39 | MP0005671_abnormal_response_to | 1.73340694 |
| 40 | MP0003172_abnormal_lysosome_physiology | 1.72037951 |
| 41 | MP0001845_abnormal_inflammatory_respons | 1.70148445 |
| 42 | MP0001849_ear_inflammation | 1.66508901 |
| 43 | MP0002139_abnormal_hepatobiliary_system | 1.64195370 |
| 44 | MP0000465_gastrointestinal_hemorrhage | 1.57898079 |
| 45 | MP0000678_abnormal_parathyroid_gland | 1.55507821 |
| 46 | MP0002166_altered_tumor_susceptibility | 1.54123333 |
| 47 | MP0008469_abnormal_protein_level | 1.53407776 |
| 48 | MP0005501_abnormal_skin_physiology | 1.53052932 |
| 49 | MP0009278_abnormal_bone_marrow | 1.52826376 |
| 50 | MP0004947_skin_inflammation | 1.52428927 |
| 51 | MP0002405_respiratory_system_inflammati | 1.51353712 |
| 52 | MP0000858_altered_metastatic_potential | 1.49303860 |
| 53 | MP0005397_hematopoietic_system_phenotyp | 1.47549700 |
| 54 | MP0001545_abnormal_hematopoietic_system | 1.47549700 |
| 55 | MP0000716_abnormal_immune_system | 1.47440691 |
| 56 | MP0005174_abnormal_tail_pigmentation | 1.43826159 |
| 57 | MP0002006_tumorigenesis | 1.43280572 |
| 58 | MP0005409_darkened_coat_color | 1.42364535 |
| 59 | MP0002398_abnormal_bone_marrow | 1.41235660 |
| 60 | MP0000343_altered_response_to | 1.39801132 |
| 61 | MP0004185_abnormal_adipocyte_glucose | 1.37444012 |
| 62 | MP0010352_gastrointestinal_tract_polyps | 1.37047419 |
| 63 | MP0005310_abnormal_salivary_gland | 1.36151123 |
| 64 | MP0003866_abnormal_defecation | 1.34306860 |
| 65 | MP0004264_abnormal_extraembryonic_tissu | 1.33733580 |
| 66 | MP0002429_abnormal_blood_cell | 1.33665438 |
| 67 | MP0004782_abnormal_surfactant_physiolog | 1.33414613 |
| 68 | MP0009764_decreased_sensitivity_to | 1.33208919 |
| 69 | MP0004858_abnormal_nervous_system | 1.32661418 |
| 70 | MP0000689_abnormal_spleen_morphology | 1.32477281 |
| 71 | MP0001853_heart_inflammation | 1.32368692 |
| 72 | MP0010307_abnormal_tumor_latency | 1.31624807 |
| 73 | MP0003448_altered_tumor_morphology | 1.29340734 |
| 74 | MP0006054_spinal_hemorrhage | 1.29255959 |
| 75 | MP0003566_abnormal_cell_adhesion | 1.26460238 |
| 76 | MP0002722_abnormal_immune_system | 1.24496230 |
| 77 | MP0002060_abnormal_skin_morphology | 1.23068741 |
| 78 | MP0005257_abnormal_intraocular_pressure | 1.22486252 |
| 79 | MP0008004_abnormal_stomach_pH | 1.21155078 |
| 80 | MP0003091_abnormal_cell_migration | 1.19873070 |
| 81 | MP0001666_abnormal_nutrient_absorption | 1.16713276 |
| 82 | MP0003111_abnormal_nucleus_morphology | 1.16116073 |
| 83 | MP0001216_abnormal_epidermal_layer | 1.13322333 |
| 84 | MP0003186_abnormal_redox_activity | 1.12441025 |
| 85 | MP0001663_abnormal_digestive_system | 1.08476222 |
| 86 | MP0005076_abnormal_cell_differentiation | 1.08422846 |
| 87 | MP0004233_abnormal_muscle_weight | 1.07586345 |
| 88 | MP0003075_altered_response_to | 1.06174803 |
| 89 | MP0004808_abnormal_hematopoietic_stem | 1.03441817 |
| 90 | MP0003828_pulmonary_edema | 1.00992241 |
| 91 | MP0004272_abnormal_basement_membrane | 0.99362587 |
| 92 | MP0008260_abnormal_autophagy | 0.98768314 |
| 93 | MP0002998_abnormal_bone_remodeling | 0.97378736 |
| 94 | MP0008007_abnormal_cellular_replicative | 0.97341449 |
| 95 | MP0003763_abnormal_thymus_physiology | 0.96844866 |
| 96 | MP0001730_embryonic_growth_arrest | 0.93981335 |
| 97 | MP0005365_abnormal_bile_salt | 0.92888083 |
| 98 | MP0005166_decreased_susceptibility_to | 0.91520502 |
| 99 | MP0005666_abnormal_adipose_tissue | 0.91023756 |
| 100 | MP0000477_abnormal_intestine_morphology | 0.89384971 |
| 101 | MP0002132_abnormal_respiratory_system | 0.89071750 |
| 102 | MP0005165_increased_susceptibility_to | 0.86952741 |
| 103 | MP0003705_abnormal_hypodermis_morpholog | 0.85236207 |
| 104 | MP0005390_skeleton_phenotype | 0.85220770 |
| 105 | MP0001958_emphysema | 0.84725168 |
| 106 | MP0002019_abnormal_tumor_incidence | 0.84313290 |
| 107 | MP0005023_abnormal_wound_healing | 0.84088414 |
| 108 | MP0001851_eye_inflammation | 0.84071692 |
| 109 | MP0005319_abnormal_enzyme/_coenzyme | 0.83532967 |
| 110 | MP0009643_abnormal_urine_homeostasis | 0.83310953 |
| 111 | MP0002277_abnormal_respiratory_mucosa | 0.83240883 |
| 112 | MP0000467_abnormal_esophagus_morphology | 0.83057227 |
| 113 | MP0000569_abnormal_digit_pigmentation | 0.82531340 |
| 114 | MP0005360_urolithiasis | 0.82461542 |
| 115 | MP0003077_abnormal_cell_cycle | 0.81991811 |
| 116 | MP0004957_abnormal_blastocyst_morpholog | 0.81473458 |
| 117 | MP0009931_abnormal_skin_appearance | 0.80994944 |
| 118 | MP0002136_abnormal_kidney_physiology | 0.80823768 |
| 119 | MP0000371_diluted_coat_color | 0.80820792 |
| 120 | MP0001881_abnormal_mammary_gland | 0.80782375 |
| 121 | MP0002933_joint_inflammation | 0.80732675 |
| 122 | MP0005621_abnormal_cell_physiology | 0.79235037 |
| 123 | MP0000537_abnormal_urethra_morphology | 0.76951208 |
| 124 | MP0002098_abnormal_vibrissa_morphology | 0.76840794 |
| 125 | MP0000598_abnormal_liver_morphology | 0.76517535 |
| 126 | MP0009763_increased_sensitivity_to | 0.75891518 |
| 127 | MP0003279_aneurysm | 0.75804676 |
| 128 | MP0000249_abnormal_blood_vessel | 0.75475827 |
| 129 | MP0000609_abnormal_liver_physiology | 0.75283372 |
| 130 | MP0003941_abnormal_skin_development | 0.74691818 |
| 131 | MP0005381_digestive/alimentary_phenotyp | 0.74486787 |
| 132 | MP0000681_abnormal_thyroid_gland | 0.74338786 |
| 133 | MP0003656_abnormal_erythrocyte_physiolo | 0.74260179 |
| 134 | MP0010368_abnormal_lymphatic_system | 0.73949317 |
| 135 | MP0002896_abnormal_bone_mineralization | 0.73079731 |
| 136 | MP0002254_reproductive_system_inflammat | 0.72856781 |
| 137 | MP0000767_abnormal_smooth_muscle | 0.71603821 |
| 138 | MP0005083_abnormal_biliary_tract | 0.69741985 |
| 139 | MP0000703_abnormal_thymus_morphology | 0.65751772 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Recurrent abscess formation (HP:0002722) | 5.57843687 |
| 2 | Eczematoid dermatitis (HP:0000976) | 5.33659770 |
| 3 | Recurrent bacterial skin infections (HP:0005406) | 5.06054743 |
| 4 | Vacuolated lymphocytes (HP:0001922) | 4.57898230 |
| 5 | Recurrent gram-negative bacterial infections (HP:0005420) | 4.26477918 |
| 6 | Abnormality of macrophages (HP:0004311) | 4.06202913 |
| 7 | Systemic lupus erythematosus (HP:0002725) | 3.96159540 |
| 8 | Elevated erythrocyte sedimentation rate (HP:0003565) | 3.56976589 |
| 9 | Myositis (HP:0100614) | 3.49112029 |
| 10 | Pustule (HP:0200039) | 3.43238838 |
| 11 | Vertebral compression fractures (HP:0002953) | 3.40251420 |
| 12 | Abnormality of liposaccharide metabolism (HP:0010968) | 3.31186990 |
| 13 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 3.31186990 |
| 14 | Abnormality of glycolipid metabolism (HP:0010969) | 3.31186990 |
| 15 | Recurrent fungal infections (HP:0002841) | 3.28208970 |
| 16 | Thrombocytosis (HP:0001894) | 3.25219977 |
| 17 | Dysostosis multiplex (HP:0000943) | 3.24448188 |
| 18 | Obstructive lung disease (HP:0006536) | 3.21064982 |
| 19 | Chronic obstructive pulmonary disease (HP:0006510) | 3.21064982 |
| 20 | Increased cerebral lipofuscin (HP:0011813) | 3.16308716 |
| 21 | Premature rupture of membranes (HP:0001788) | 3.15763824 |
| 22 | Recurrent skin infections (HP:0001581) | 3.13021350 |
| 23 | Gingivitis (HP:0000230) | 3.12523961 |
| 24 | Thin bony cortex (HP:0002753) | 2.99225263 |
| 25 | Mucopolysacchariduria (HP:0008155) | 2.95740849 |
| 26 | Urinary glycosaminoglycan excretion (HP:0003541) | 2.95740849 |
| 27 | Petechiae (HP:0000967) | 2.95472144 |
| 28 | Orchitis (HP:0100796) | 2.94183903 |
| 29 | Autoimmune thrombocytopenia (HP:0001973) | 2.90881955 |
| 30 | Protrusio acetabuli (HP:0003179) | 2.86545511 |
| 31 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 2.86327625 |
| 32 | Abnormality of polysaccharide metabolism (HP:0011012) | 2.86327625 |
| 33 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 2.86327625 |
| 34 | Periodontitis (HP:0000704) | 2.85702554 |
| 35 | Chronic otitis media (HP:0000389) | 2.82735575 |
| 36 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 2.82593422 |
| 37 | Interstitial pulmonary disease (HP:0006530) | 2.81760316 |
| 38 | Flat acetabular roof (HP:0003180) | 2.81439231 |
| 39 | Mediastinal lymphadenopathy (HP:0100721) | 2.78669299 |
| 40 | Cheilitis (HP:0100825) | 2.73285170 |
| 41 | Abnormality of the distal phalanges of the toes (HP:0010182) | 2.72757061 |
| 42 | Recurrent viral infections (HP:0004429) | 2.71644609 |
| 43 | Malnutrition (HP:0004395) | 2.61293407 |
| 44 | IgM deficiency (HP:0002850) | 2.58576577 |
| 45 | Glomerulonephritis (HP:0000099) | 2.57669950 |
| 46 | Thoracic kyphosis (HP:0002942) | 2.56981964 |
| 47 | Spontaneous hematomas (HP:0007420) | 2.55101914 |
| 48 | Urticaria (HP:0001025) | 2.45048577 |
| 49 | Upper limb amyotrophy (HP:0009129) | 2.39281816 |
| 50 | Distal upper limb amyotrophy (HP:0007149) | 2.39281816 |
| 51 | Abnormality of T cell physiology (HP:0011840) | 2.39269393 |
| 52 | Poor head control (HP:0002421) | 2.37920481 |
| 53 | Cellulitis (HP:0100658) | 2.37501024 |
| 54 | Distal lower limb muscle weakness (HP:0009053) | 2.34710937 |
| 55 | Agnosia (HP:0010524) | 2.31906419 |
| 56 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 2.28990318 |
| 57 | Optic neuritis (HP:0100653) | 2.27380281 |
| 58 | Retrobulbar optic neuritis (HP:0100654) | 2.27380281 |
| 59 | Achilles tendon contracture (HP:0001771) | 2.26548072 |
| 60 | Meningitis (HP:0001287) | 2.25871997 |
| 61 | Reduced antithrombin III activity (HP:0001976) | 2.24797298 |
| 62 | Abnormality of the thoracic spine (HP:0100711) | 2.23882069 |
| 63 | Prostate neoplasm (HP:0100787) | 2.22272487 |
| 64 | Vasculitis (HP:0002633) | 2.22100416 |
| 65 | Osteomyelitis (HP:0002754) | 2.21383750 |
| 66 | Recurrent cutaneous fungal infections (HP:0011370) | 2.21259218 |
| 67 | Chronic mucocutaneous candidiasis (HP:0002728) | 2.21259218 |
| 68 | Abnormality of the prostate (HP:0008775) | 2.19940647 |
| 69 | Basal ganglia calcification (HP:0002135) | 2.19881214 |
| 70 | Upper motor neuron abnormality (HP:0002127) | 2.19863100 |
| 71 | Cervical subluxation (HP:0003308) | 2.15181554 |
| 72 | Osteolytic defects of the phalanges of the hand (HP:0009771) | 2.13733713 |
| 73 | Osteolytic defects of the hand bones (HP:0009699) | 2.13733713 |
| 74 | Abnormality of the lumbar spine (HP:0100712) | 2.13690018 |
| 75 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 2.13041171 |
| 76 | Hemorrhage of the eye (HP:0011885) | 2.12283145 |
| 77 | Impaired platelet aggregation (HP:0003540) | 2.11533912 |
| 78 | Abnormal platelet function (HP:0011869) | 2.11533912 |
| 79 | Short nail (HP:0001799) | 2.10229999 |
| 80 | Hyperparathyroidism (HP:0000843) | 2.10080726 |
| 81 | Aplastic anemia (HP:0001915) | 2.09320032 |
| 82 | Abnormality of the Achilles tendon (HP:0005109) | 2.09028442 |
| 83 | Distal lower limb amyotrophy (HP:0008944) | 2.08484224 |
| 84 | Albinism (HP:0001022) | 2.07658890 |
| 85 | Primitive reflexes (palmomental, snout, glabellar) (HP:0002476) | 2.07139149 |
| 86 | Cerebral aneurysm (HP:0004944) | 2.06394813 |
| 87 | Gastrointestinal inflammation (HP:0004386) | 2.06168744 |
| 88 | Inflammation of the large intestine (HP:0002037) | 2.05418874 |
| 89 | Increased connective tissue (HP:0009025) | 2.04740964 |
| 90 | Trismus (HP:0000211) | 2.03136545 |
| 91 | Hepatosplenomegaly (HP:0001433) | 2.02371077 |
| 92 | Abnormality of complement system (HP:0005339) | 2.01663442 |
| 93 | Gingival bleeding (HP:0000225) | 1.99847772 |
| 94 | Hand muscle atrophy (HP:0009130) | 1.97457391 |
| 95 | Abnormality of the nasal mucosa (HP:0000433) | 1.97354311 |
| 96 | Prolonged bleeding time (HP:0003010) | 1.97326441 |
| 97 | Disinhibition (HP:0000734) | 1.97325524 |
| 98 | Broad face (HP:0000283) | 1.96979487 |
| 99 | Granulocytopenia (HP:0001913) | 1.96726679 |
| 100 | Leukocytosis (HP:0001974) | 1.96554931 |
| 101 | Hyperacusis (HP:0010780) | 1.96311308 |
| 102 | Fragile skin (HP:0001030) | 1.95361924 |
| 103 | Recurrent pneumonia (HP:0006532) | 1.94181390 |
| 104 | Epistaxis (HP:0000421) | 1.93735161 |
| 105 | Pulmonary infiltrates (HP:0002113) | 1.93621662 |
| 106 | Increased IgE level (HP:0003212) | 1.93308597 |
| 107 | Arterial thrombosis (HP:0004420) | 1.93162202 |
| 108 | Skin ulcer (HP:0200042) | 1.92744630 |
| 109 | Axonal loss (HP:0003447) | 1.92122442 |
| 110 | J-shaped sella turcica (HP:0002680) | 1.91419946 |
| 111 | Abdominal distention (HP:0003270) | 1.90265229 |
| 112 | Eosinophilia (HP:0001880) | 1.88533580 |
| 113 | Elevated alkaline phosphatase (HP:0003155) | 1.88512811 |
| 114 | Joint hemorrhage (HP:0005261) | 1.88329202 |
| 115 | Disproportionate tall stature (HP:0001519) | 1.88118408 |
| 116 | Hemoptysis (HP:0002105) | 1.86856549 |
| 117 | Polygenic inheritance (HP:0010982) | 1.86299467 |
| 118 | Anorexia (HP:0002039) | 1.86052307 |
| 119 | Abnormal gallbladder physiology (HP:0012438) | 1.85745919 |
| 120 | Cholecystitis (HP:0001082) | 1.85745919 |
| 121 | Blue sclerae (HP:0000592) | 1.85440859 |
| 122 | Myocardial infarction (HP:0001658) | 1.85042277 |
| 123 | Chest pain (HP:0100749) | 1.84893651 |
| 124 | Atrophic scars (HP:0001075) | 1.81155932 |
| 125 | Ankyloglossia (HP:0010296) | 1.80745885 |
| 126 | Purpura (HP:0000979) | 1.79883847 |
| 127 | Abnormality of alkaline phosphatase activity (HP:0004379) | 1.79829128 |
| 128 | Nephritis (HP:0000123) | 1.79254086 |
| 129 | Pathologic fracture (HP:0002756) | 1.79185244 |
| 130 | Loss of speech (HP:0002371) | 1.78691080 |
| 131 | Abnormal enzyme/coenzyme activity (HP:0012379) | 1.77520404 |
| 132 | Esophageal varix (HP:0002040) | 1.76808164 |
| 133 | Amyloidosis (HP:0011034) | 1.76796783 |
| 134 | Abnormality of T cells (HP:0002843) | 1.76685021 |
| 135 | Nasal polyposis (HP:0100582) | 1.76524906 |
| 136 | Abnormality of the acetabulum (HP:0003170) | 1.74376697 |
| 137 | Increased serum ferritin (HP:0003281) | 1.74202696 |
| 138 | Hypertensive crisis (HP:0100735) | 1.73683689 |
| 139 | Dilatation of the ascending aorta (HP:0005111) | 1.72677936 |
| 140 | Ulnar bowing (HP:0003031) | 1.72182866 |
| 141 | Centrally nucleated skeletal muscle fibers (HP:0003687) | 1.71278216 |
| 142 | Chromosomal breakage induced by crosslinking agents (HP:0003221) | 1.70997651 |
| 143 | Recurrent lower respiratory tract infections (HP:0002783) | 1.70954977 |
| 144 | Polycythemia (HP:0001901) | 1.70243545 |
| 145 | Bone pain (HP:0002653) | 1.69678691 |
| 146 | Nausea (HP:0002018) | 1.68831229 |
| 147 | Abnormality of oral frenula (HP:0000190) | 1.68709515 |
| 148 | Stridor (HP:0010307) | 1.68554750 |
| 149 | Hematochezia (HP:0002573) | 1.67146190 |
| 150 | Encephalitis (HP:0002383) | 1.66855429 |
| 151 | Progressive neurologic deterioration (HP:0002344) | 1.66297581 |
| 152 | Colitis (HP:0002583) | 1.65921227 |
| 153 | Ragged-red muscle fibers (HP:0003200) | 1.65856752 |
| 154 | Poikiloderma (HP:0001029) | 1.65596154 |
| 155 | Abnormal trabecular bone morphology (HP:0100671) | 1.65203867 |
| 156 | Nuclear cataract (HP:0100018) | 1.64089893 |
| 157 | Atelectasis (HP:0100750) | 1.63664439 |
| 158 | Right ventricular cardiomyopathy (HP:0011663) | 1.63312191 |
| 159 | Generalized amyotrophy (HP:0003700) | 1.63032971 |
| 160 | Prolonged neonatal jaundice (HP:0006579) | 1.62975726 |
| 161 | Aneurysm (HP:0002617) | 1.62589162 |
| 162 | Long palpebral fissure (HP:0000637) | 1.62324423 |
| 163 | Ankle contracture (HP:0006466) | 1.61360310 |
| 164 | Abnormality of carpal bone ossification (HP:0006257) | 1.60748836 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | IRAK3 | 3.55709612 |
| 2 | SMG1 | 3.37581231 |
| 3 | ERN1 | 3.18794494 |
| 4 | IRAK4 | 2.89219010 |
| 5 | BLK | 2.83961558 |
| 6 | MAP4K1 | 2.77485384 |
| 7 | PRPF4B | 2.37698437 |
| 8 | TYK2 | 2.28661055 |
| 9 | EPHA2 | 2.22639565 |
| 10 | TBK1 | 2.17690180 |
| 11 | SIK1 | 2.17558949 |
| 12 | TAOK3 | 2.06018622 |
| 13 | ICK | 2.04337563 |
| 14 | PIM2 | 1.96559811 |
| 15 | MAP3K14 | 1.90977609 |
| 16 | CDK12 | 1.89368161 |
| 17 | KIT | 1.80389720 |
| 18 | MAP2K3 | 1.74260034 |
| 19 | NME2 | 1.74108047 |
| 20 | ZAP70 | 1.72609240 |
| 21 | PAK4 | 1.70291976 |
| 22 | JAK3 | 1.69301296 |
| 23 | BTK | 1.67647090 |
| 24 | BUB1 | 1.64110961 |
| 25 | STK16 | 1.63638268 |
| 26 | TESK1 | 1.63341203 |
| 27 | STK10 | 1.62938815 |
| 28 | EIF2AK1 | 1.57364352 |
| 29 | TEC | 1.54864581 |
| 30 | TESK2 | 1.52247873 |
| 31 | MAP3K3 | 1.50205770 |
| 32 | MAP3K11 | 1.49296768 |
| 33 | KSR2 | 1.49178036 |
| 34 | IKBKE | 1.41700182 |
| 35 | EEF2K | 1.40376087 |
| 36 | CSF1R | 1.37401243 |
| 37 | PTK6 | 1.36915495 |
| 38 | MAP2K2 | 1.33350337 |
| 39 | TRIB3 | 1.30618605 |
| 40 | MAP3K13 | 1.28075823 |
| 41 | IKBKB | 1.25756751 |
| 42 | EIF2AK3 | 1.25080213 |
| 43 | PDGFRA | 1.22025007 |
| 44 | TGFBR2 | 1.21481257 |
| 45 | RPS6KA4 | 1.21408835 |
| 46 | PRKG2 | 1.20400967 |
| 47 | KDR | 1.18575035 |
| 48 | ARAF | 1.16589840 |
| 49 | EPHB1 | 1.15292009 |
| 50 | FGFR4 | 1.13527525 |
| 51 | NEK2 | 1.12529937 |
| 52 | SCYL2 | 1.12379320 |
| 53 | MET | 1.10825763 |
| 54 | TAOK1 | 1.10041726 |
| 55 | MAP3K1 | 1.09176894 |
| 56 | TXK | 1.08911456 |
| 57 | RIPK4 | 1.08422429 |
| 58 | MAP3K2 | 1.07234246 |
| 59 | WEE1 | 1.04105240 |
| 60 | PTK2 | 1.04003416 |
| 61 | LMTK2 | 0.98760396 |
| 62 | CAMKK2 | 0.98568890 |
| 63 | MST1R | 0.92696362 |
| 64 | JAK1 | 0.91684761 |
| 65 | PRKD2 | 0.91355780 |
| 66 | FRK | 0.90999647 |
| 67 | BCKDK | 0.90813606 |
| 68 | NEK9 | 0.90449540 |
| 69 | LRRK2 | 0.89961768 |
| 70 | PKN2 | 0.89257300 |
| 71 | CDC42BPA | 0.88810329 |
| 72 | CSK | 0.88028719 |
| 73 | MATK | 0.87179886 |
| 74 | RPS6KB2 | 0.86683676 |
| 75 | FES | 0.86523965 |
| 76 | MAP3K10 | 0.84336327 |
| 77 | MAP3K8 | 0.83252762 |
| 78 | PDPK1 | 0.82334414 |
| 79 | HCK | 0.81791736 |
| 80 | PBK | 0.81722648 |
| 81 | LYN | 0.81297540 |
| 82 | SYK | 0.80832416 |
| 83 | TAOK2 | 0.79258195 |
| 84 | PIM1 | 0.78385764 |
| 85 | RIPK1 | 0.77080057 |
| 86 | SIK3 | 0.76416745 |
| 87 | BRAF | 0.76273984 |
| 88 | LATS2 | 0.76263864 |
| 89 | CAMK1D | 0.76202850 |
| 90 | TTK | 0.75264232 |
| 91 | JAK2 | 0.74472382 |
| 92 | AKT3 | 0.72233318 |
| 93 | PLK4 | 0.72040652 |
| 94 | CLK1 | 0.71265880 |
| 95 | MTOR | 0.70194088 |
| 96 | IRAK2 | 0.69529523 |
| 97 | FLT3 | 0.68660015 |
| 98 | CHUK | 0.66281964 |
| 99 | DDR2 | 0.66158656 |
| 100 | GRK6 | 0.63670899 |
| 101 | BRSK2 | 0.63369182 |
| 102 | CDK6 | 0.62833610 |
| 103 | STK24 | 0.61352482 |
| 104 | MAP3K6 | 0.61285774 |
| 105 | LCK | 0.61018408 |
| 106 | CDK7 | 0.59624597 |
| 107 | EIF2AK2 | 0.58565848 |
| 108 | PRKD3 | 0.56959621 |
| 109 | CDK4 | 0.56504851 |
| 110 | FGR | 0.54448719 |
| 111 | RPS6KA6 | 0.52572887 |
| 112 | ACVR1B | 0.52518137 |
| 113 | ITK | 0.50504028 |
| 114 | YES1 | 0.49677072 |
| 115 | MST4 | 0.47764469 |
| 116 | ABL2 | 0.47694237 |
| 117 | MARK2 | 0.47657980 |
| 118 | TRPM7 | 0.47648412 |
| 119 | TSSK6 | 0.47573034 |
| 120 | NEK1 | 0.47477166 |
| 121 | PRKCD | 0.46884551 |
| 122 | MAP3K12 | 0.46700521 |
| 123 | ATR | 0.45597651 |
| 124 | BMX | 0.45542100 |
| 125 | TTN | 0.45514676 |
| 126 | RPS6KC1 | 0.45492249 |
| 127 | RPS6KL1 | 0.45492249 |
| 128 | MARK3 | 0.45373997 |
| 129 | MAPK11 | 0.45272028 |
| 130 | MAPK4 | 0.45219626 |
| 131 | MELK | 0.44587895 |
| 132 | STK4 | 0.43952064 |
| 133 | NUAK1 | 0.42976649 |
| 134 | RPS6KA2 | 0.42870995 |
| 135 | PAK1 | 0.42229285 |
| 136 | MAPKAPK2 | 0.41242858 |
| 137 | AURKB | 0.40865880 |
| 138 | CDK8 | 0.40047576 |
| 139 | MOS | 0.40013248 |
| 140 | ILK | 0.39538414 |
| 141 | ZAK | 0.39047959 |
| 142 | MAPKAPK3 | 0.38883089 |
| 143 | STK38 | 0.38820178 |
| 144 | PDGFRB | 0.37576245 |
| 145 | CDK9 | 0.33631885 |
| 146 | AURKA | 0.32297215 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Other glycan degradation_Homo sapiens_hsa00511 | 3.10319795 |
| 2 | Leishmaniasis_Homo sapiens_hsa05140 | 2.79293282 |
| 3 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 2.54891928 |
| 4 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 2.53132860 |
| 5 | Lysosome_Homo sapiens_hsa04142 | 2.29775380 |
| 6 | DNA replication_Homo sapiens_hsa03030 | 2.26874681 |
| 7 | Legionellosis_Homo sapiens_hsa05134 | 2.12945044 |
| 8 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 2.00672232 |
| 9 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 1.94540439 |
| 10 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 1.94187997 |
| 11 | Pertussis_Homo sapiens_hsa05133 | 1.91069291 |
| 12 | Osteoclast differentiation_Homo sapiens_hsa04380 | 1.78123577 |
| 13 | Bladder cancer_Homo sapiens_hsa05219 | 1.75293593 |
| 14 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 1.70491446 |
| 15 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 1.68344664 |
| 16 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 1.66093720 |
| 17 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 1.58972003 |
| 18 | Antigen processing and presentation_Homo sapiens_hsa04612 | 1.58037188 |
| 19 | Measles_Homo sapiens_hsa05162 | 1.55782270 |
| 20 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 1.55380556 |
| 21 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 1.51721753 |
| 22 | Tuberculosis_Homo sapiens_hsa05152 | 1.51625490 |
| 23 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 1.51051034 |
| 24 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 1.48829581 |
| 25 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 1.48443286 |
| 26 | Influenza A_Homo sapiens_hsa05164 | 1.45702007 |
| 27 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 1.44438754 |
| 28 | Shigellosis_Homo sapiens_hsa05131 | 1.44165080 |
| 29 | Apoptosis_Homo sapiens_hsa04210 | 1.43894045 |
| 30 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 1.34423106 |
| 31 | Herpes simplex infection_Homo sapiens_hsa05168 | 1.32512142 |
| 32 | Base excision repair_Homo sapiens_hsa03410 | 1.31927657 |
| 33 | Mismatch repair_Homo sapiens_hsa03430 | 1.28015706 |
| 34 | Proteasome_Homo sapiens_hsa03050 | 1.27339493 |
| 35 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.25640703 |
| 36 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 1.24890280 |
| 37 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 1.24085284 |
| 38 | Renin-angiotensin system_Homo sapiens_hsa04614 | 1.23952663 |
| 39 | Prion diseases_Homo sapiens_hsa05020 | 1.22566287 |
| 40 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 1.22201740 |
| 41 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 1.21314931 |
| 42 | TNF signaling pathway_Homo sapiens_hsa04668 | 1.18741297 |
| 43 | Salmonella infection_Homo sapiens_hsa05132 | 1.17735187 |
| 44 | Folate biosynthesis_Homo sapiens_hsa00790 | 1.15385089 |
| 45 | Malaria_Homo sapiens_hsa05144 | 1.13347904 |
| 46 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 1.12244707 |
| 47 | Phagosome_Homo sapiens_hsa04145 | 1.11661194 |
| 48 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.09970132 |
| 49 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 1.09449792 |
| 50 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 1.09213974 |
| 51 | Thyroid cancer_Homo sapiens_hsa05216 | 1.08716124 |
| 52 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 1.07951296 |
| 53 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.07864864 |
| 54 | Notch signaling pathway_Homo sapiens_hsa04330 | 1.07140992 |
| 55 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 1.01815028 |
| 56 | Hepatitis C_Homo sapiens_hsa05160 | 1.01106990 |
| 57 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 1.00777140 |
| 58 | Carbon metabolism_Homo sapiens_hsa01200 | 1.00258785 |
| 59 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.97380010 |
| 60 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.96423061 |
| 61 | Homologous recombination_Homo sapiens_hsa03440 | 0.96023876 |
| 62 | Fat digestion and absorption_Homo sapiens_hsa04975 | 0.95054737 |
| 63 | Hepatitis B_Homo sapiens_hsa05161 | 0.94343266 |
| 64 | Galactose metabolism_Homo sapiens_hsa00052 | 0.93411848 |
| 65 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.92735985 |
| 66 | One carbon pool by folate_Homo sapiens_hsa00670 | 0.92676613 |
| 67 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 0.90905766 |
| 68 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.85994064 |
| 69 | Asthma_Homo sapiens_hsa05310 | 0.83890862 |
| 70 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.83016861 |
| 71 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 0.82821757 |
| 72 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.82608823 |
| 73 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 0.81649799 |
| 74 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.81621892 |
| 75 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 0.80693432 |
| 76 | Pyrimidine metabolism_Homo sapiens_hsa00240 | 0.80145399 |
| 77 | Sulfur relay system_Homo sapiens_hsa04122 | 0.79598769 |
| 78 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.77389138 |
| 79 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.77232192 |
| 80 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.76155892 |
| 81 | Primary immunodeficiency_Homo sapiens_hsa05340 | 0.75989571 |
| 82 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.74615097 |
| 83 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.72887667 |
| 84 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 0.72819244 |
| 85 | Endocytosis_Homo sapiens_hsa04144 | 0.72724036 |
| 86 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.71995457 |
| 87 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.71707007 |
| 88 | Histidine metabolism_Homo sapiens_hsa00340 | 0.71528185 |
| 89 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.71377928 |
| 90 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.70402784 |
| 91 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.70381063 |
| 92 | Sulfur metabolism_Homo sapiens_hsa00920 | 0.69749982 |
| 93 | Mineral absorption_Homo sapiens_hsa04978 | 0.69541405 |
| 94 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.67678491 |
| 95 | Ribosome_Homo sapiens_hsa03010 | 0.67415680 |
| 96 | HTLV-I infection_Homo sapiens_hsa05166 | 0.66046317 |
| 97 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 0.66034569 |
| 98 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 0.65104390 |
| 99 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 0.64875977 |
| 100 | Arginine biosynthesis_Homo sapiens_hsa00220 | 0.64258952 |
| 101 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.63990259 |
| 102 | p53 signaling pathway_Homo sapiens_hsa04115 | 0.60584777 |
| 103 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.60464353 |
| 104 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.60084432 |
| 105 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.59659641 |
| 106 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.58438584 |
| 107 | Cell cycle_Homo sapiens_hsa04110 | 0.58417565 |
| 108 | Endometrial cancer_Homo sapiens_hsa05213 | 0.58306412 |
| 109 | Graft-versus-host disease_Homo sapiens_hsa05332 | 0.57429325 |
| 110 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.57076787 |
| 111 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.56693747 |
| 112 | Focal adhesion_Homo sapiens_hsa04510 | 0.56571537 |
| 113 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.53846650 |
| 114 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 0.53377268 |
| 115 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 0.53290427 |
| 116 | Allograft rejection_Homo sapiens_hsa05330 | 0.52820909 |
| 117 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.52515314 |
| 118 | Insulin resistance_Homo sapiens_hsa04931 | 0.52389232 |
| 119 | Prostate cancer_Homo sapiens_hsa05215 | 0.50942332 |
| 120 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.50380852 |
| 121 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.49165450 |
| 122 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.48807166 |
| 123 | Adherens junction_Homo sapiens_hsa04520 | 0.46980912 |
| 124 | Spliceosome_Homo sapiens_hsa03040 | 0.45763021 |
| 125 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.44373862 |
| 126 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.44267902 |
| 127 | Viral myocarditis_Homo sapiens_hsa05416 | 0.42618313 |
| 128 | Platelet activation_Homo sapiens_hsa04611 | 0.41996832 |
| 129 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.41438775 |
| 130 | Ribosome biogenesis in eukaryotes_Homo sapiens_hsa03008 | 0.40935569 |
| 131 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 0.40591238 |
| 132 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.40568809 |
| 133 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.40542407 |
| 134 | Aminoacyl-tRNA biosynthesis_Homo sapiens_hsa00970 | 0.39828548 |
| 135 | Tyrosine metabolism_Homo sapiens_hsa00350 | 0.38642715 |
| 136 | Amoebiasis_Homo sapiens_hsa05146 | 0.38080778 |
| 137 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 0.36246805 |

